L2M: Closed-loop vancomycin monitoring and delivery

This project aims to advance the commercialization strategy of a closed-loop microneedle-based biosensing platform for real-time therapeutic drug monitoring. The technology integrates hydrogel microneedles with electrochemical aptamer-based sensors to continuously measure drug concentrations in interstitial fluid and enable adaptive dosing. Initially developed for vancomycin monitoring, the platform addresses critical limitations of conventional therapeutic drug monitoring, including delayed laboratory results, invasive blood sampling, and population-based dosing models that do not reflect patient-specific pharmacokinetics.

Faculty Supervisor:

Mahla Poudineh

Student:

Partner:

Innovation Factory

Discipline:

Engineering

Sector:

Professional, scientific and technical services

University:

University of Waterloo

Program:

Business Strategy Internship

Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects